DCGI Approves DRDO's Anti-Coronavirus Medicine
Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the DRDO.
We all are aware that India is going through the second wave of the corona virus and the experts have also warned of the third wave. Amidst this, the Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the Defence Research and Development Organisation (DRDO). As per reports this medicine will be used to treat moderate to severe patients. The Institute of Nuclear Medicine and Allied Sciences (INMAS), the DRDO lab, along with the Hyderabad-based Dr. Reddy's Laboratories, has developed the anti-coronavirus therapeutic drug called 2-DG. The medicine comes in powder form in a sachet and can be consumed orally by dissolving it in water. The results of clinical trials for the drug showed that it helps in faster recovery of hospitalized coronavirus patients and also reduces their dependence on supplemental oxygen. There is a molecule in the medicine that stops the fatal virus from multiplying.
Scientists at INMAS-DRDO had started experimenting with this drug early last year.In the second round of trials, conducted on 110 patients, the drug was found to be safe for use in COVID-19 patients and showed significant improvement in their recovery process. Thereafter, phase three trials were conducted on 220 patients from last December to March 2021 at 27 coronavirus hospitals in several states. The drug can help save precious lives as a dreadful second wave of the coronavirus continues to kill thousands every day.
